Today on DrugResearcher.com   Addex and Merck target new cure for Parkinson's India's Glenmark pioneering through prioritising preclinical Pfizer plans more off-shoring and outsourcing Drugs moving into the clinic: 37 Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline

Related Industry News   Covance divests cardiac unit Exiqon enters cancer diagnostic field with Oncotech acquisition Paraytec to lead biopharmaceutical sizing collaboration Almirall takes on big pharma in COPD

Breaking News on Drug Discovery
Daily  Tuesday 04 December 2007		Forward to a colleague

	Sponsored Link Excellent value for money for routine moisture determination The TitraLab 580 and 585 Volumetric Karl Fischer Workstations are ideal for fast and accurate moisture determination whether you are working with solids or liquids. Operation is simple thanks to pre-programmed functions and dedicated buttons for solvent addition and cell... Click Here Access Full Stories Addex and Merck target new cure for Parkinson's Merck & Co. has entered into an exclusive collaboration and licensing deal with Addex Pharma to develop a new class of orally available Parkinson's therapies... Read India's Glenmark pioneering through prioritising preclinical Glenmark is one of a handful of pharma firms in India pushing forward a preclinical programme as a priority... Read Pfizer plans more off-shoring and outsourcing Pfizer is looking to Asia for both R&D and manufacturing outsourcing and to help it cut costs in a bid to mitigate the effects of patent expiries and competition from generic drugs... Read Drugs moving into the clinic: 37 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read Regeneron helps make Sanofi VelocImmune to its 'weak' pipeline Sanofi-Aventis recently admitted it needed to increase the number of biotech compounds in its pipeline and now, true to its word, the French pharma heavyweight has signed a big antibody deal with US biotech Regeneron... Read
	All News Headlines for: December | November | October
	Sponsored Link CappAero pipettes - ultimate accuracy and intelligent design The cool transparent handle and dash of vibrant colour on the barrel ensures the ColorLine series will be a welcome addition to any laboratory. The distinctive colour of each pipette permits you to quickly identify the volume range of any pipette at a glance... Click Here
	Related Industry News Covance divests cardiac unit Covance has announced the $35m sale of its electrocardiogram (ECG) unit in order to focus on its core businesses... Read Exiqon enters cancer diagnostic field with Oncotech acquisition Gene expression analysis expert Exiqon is to pay up to $45m (€30.7m) for diagnostics company Oncotech as a first step towards becoming a world leading miRNA diagnostic manufacturer... Read Paraytec to lead biopharmaceutical sizing collaboration Paraytec has been chosen to lead a £1m (€1.4m) consortium project to develop new analytical instruments that will detect aggregation in biopharmaceutical processing... Read Almirall takes on big pharma in COPD Spanish firm Almirall is working on a new chronic obstructive pulmonary disease (COPD) treatment combined with a hi-tech easy use inhaler, creating what it hopes will be another competitive product from its in-house... Read Weekly Comment No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma. Read Previous Headlines Jubilant Organosys eyeing up European acquisitions Indian pharma services provider Jubilant Organosys is looking to buy up European contract research organisations (CRO) and contract research and manufacturing services (CRAMS) and it has got $100m to spend, according... Read 'Technology Pioneers' elected to World Economic Forum The World Economic Forum has announced this year's 'Technology Pioneers', firms which have developed a life-changing technology innovation that has the potential for long-term impact on both business and society... Read Private equity firm puts crores into Indian CRO GVK Bio has reinforced its claim to be India's top CRO with $25m of private investment that will be used to expand its drug discovery services and push further into preclinical and clinical development... Read Xenome and Amylin team up to poison metabolic diseases Xenome, which specialises in extracting therapeutic peptides from the venom of poisonous animals has penned a deal with Amylin Pharmaceuticals to find drugs that tackle metabolic diseases such as diabetes and obesity... Read Astellas snaps up cancer antibody specialists Agensys Japanese drugmaker Astellas has agreed to acquire US biotech firm Agensys as part of its plan to ramp up antibody research, especially in the field of cancer... Read Technical / White Papers, Case studies, Web casts Benefits of integrating human tissue research in drug discovery - Technical / White Paper Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com